6505--Lenalidomide

The Department of Veterans Affairs awarded contract 36C25226P0148 to Exelan Pharmaceuticals Inc on January 16, 2026, for the procurement of Lenalidomide (Revlimid) and associated pharmaceutical services for the Edward Hines Jr. VA Hospital in Hines, Illinois. The total award amount is 3,300,314.88 dollars, covering seven different dosage forms and estimated new patient starts. The period of performance runs from January 5, 2026, through January 4, 2027. This award was based on the Lowest Price Technically Acceptable (LPTA) evaluation method, ensuring the government received the most cost-effective solution that met all technical requirements. The contractor is responsible for the end-to-end fulfillment of prescriptions, including dispensing through a certified specialty pharmacy and delivering medications directly to Veterans via next-day delivery with signature requirements. A critical component of the contract is strict adherence to the Lenalidomide REMS program, which requires the vendor to be a certified REMS pharmacy, ensure patient enrollment, and perform documented patient counseling. Administrative requirements include electronic invoicing through the VA Electronic Invoice Presentment and Payment System (EIPPS) or the Tungsten Network, with all shipments delivered FOB Destination to the Edward Hines Jr. VA Hospital Pharmacy Department.